Filing Details

Accession Number:
0001181431-12-039761
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-07-05 16:21:45
Reporting Period:
2012-07-03
Filing Date:
2012-07-05
Accepted Time:
2012-07-05 16:21:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1325879 Aveo Pharmaceuticals Inc AVEO Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1486428 William Slichenmyer C/O Aveo Pharmaceuticals, Inc.
75 Sidney Street
Cambridge MA 02139
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-07-03 1,000 $9.64 24,693 No 4 M Direct
Common Stock Disposition 2012-07-03 1,000 $13.00 23,693 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2012-07-03 1,000 $0.00 1,000 $9.64
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
110,500 2019-10-08 No 4 M Direct
Footnotes
  1. The exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2010.
  2. The option vested as to 25% of the shares on September 14, 2010 and thereafter vests in equal monthly installments as to the remaining shares through September 14, 2013.